Mannkind stock price target

MannKind Corporation (MNKD) Stock: Headed Up On Analyst ...

MANNKIND CORPORATION : MNKD Stock Price | MarketScreener MannKind Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. Its product candidate is AFREZZA, which is an inhaled insulin used to control high blood sugar in adults with type I and type II MNKD - MannKind Corporation Summary, Stock ... - Benzinga Jan 01, 2010 · MannKind Corporation (NASDAQ: MNKD) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on

Stock quote for MannKind Corporation Common Stock Common Stock (MNKD) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.

Mannkind: Analysts' Upgrades, Downgrades - TheStreet Jan 20, 2011 · Mannkind downgraded at Wells Fargo from Outperform to Market Perform. Green and red arrows refer to intraday stock price movement. NEW YORK ( … MNKD MannKind Corp. — Stock Price and Discussion | Stocktwits Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.

MannKind Corporation (MNKD) Stock Price, Quote, History ...

MNKD Stock Price | MannKind Corp. Stock Quote (U.S ... MannKind's stock extends slide, plunges 19% in active trade Oct. 11, 2017 at 12:03 p.m. ET by Tomi Kilgore MannKind's stock tumbles after share offering, in wake of recent tripling in price Could MannKind Corporation Be a Millionaire-Maker Stock ... Without setting a solid plan for how MannKind can raise capital on favorable terms, for instance, the firm has stood by its juicy $7 price target, implying a monstrous 250% upside potential from MannKind Stock Forecast: down to 0.000001 USD? - MNKD ...

5 brokerages have issued 12-month price objectives for MannKind's stock. Their forecasts range from $2.50 to $3.00. On average, they expect MannKind's stock price to reach $2.75 in the next twelve months. This suggests a possible upside of 191.9% from the stock's …

Mar 11, 2020 · MannKind Corporation is said to have a 12-month price target set at $2.80. That means that the stock has a strong potential to acquire 1.7% increase from the current trading price. MannKind Corporation [NASDAQ:MNKD]: Analyst Rating and Earnings. This is … MannKind: Afrezza Is Worthless - MannKind Corporation ... Aug 03, 2018 · MannKind appears vastly overvalued. We will initiate a "short" rating with a price target of $0.50 and urge long investors to jump boat before it sinks. According to MannKind Corporation's ( … MannKind Corporation (MNKD) Stock: Headed Up On Analyst ... MannKind Corporation (MNKD) Stock: Headed Up On Analyst Initiations. By. Joshua Rodriguez - The analyst did not provide a price target, but rated the stock as an Outperform.

MNKD Stock Quote - MannKind Corporation Common Stock Price ...

MannKind Price Target | MNKD View Price Target for MNKD Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. MannKind (MNKD) Stock Sliding Following Price Target Cut ... May 08, 2015 · NEW YORK -- Shares of MannKind () - Get Report were sliding, down 3.98% to $3.86 in midday trading Friday, after analysts at Piper Jaffray slashed … MNKD Stock Price and Chart — NASDAQ:MNKD — TradingView View live MANNKIND CORPORATION chart to track its stock's price action. Find market predictions, MNKD financials and market news. View live MANNKIND CORPORATION chart to track its stock's price action. Find market predictions, MNKD financials and market news. TradingView . EN. MannKind Corp. is a biopharmaceutical company. It focuses on the

MNKD: MannKind Corporation - Price & Consenus Chart ... MNKD: MannKind Corporation - Price and Consensus Chart. Get the latest Price and Consensus Chart for MannKind Corporation from Zacks Investment Research MannKind Corporation [MNKD] Price Analysis: NASDAQ:MNKD ... Mar 17, 2020 · MannKind Corporation is said to have a 12-month price target set at $3.00. That means that the stock has a strong potential to acquire 1.97% increase from the current trading price. MannKind Corporation [NASDAQ:MNKD]: Analyst Rating and Earnings. This is … Mannkind Corporation - MNKD - Stock Price Today - Zacks Get the latest MannKind Corporation MNKD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Mannkind Corporation - MNKD - Stock Price Today - Zacks MNKD is down -1.46% today, MannKind Corp, MNKD:NMQ forecasts - FT.com